CSI position statement on management of heart failure in India

about

CSI position statement on management of heart failure in India

Item

http://www.wikidata.org/entity/Q57665132

description

im Juli 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 08 June 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

CSI position statement on management of heart failure in India

@en

CSI position statement on management of heart failure in India

@nl

type

Item

label

CSI position statement on management of heart failure in India

@en

CSI position statement on management of heart failure in India

@nl

prefLabel

CSI position statement on management of heart failure in India

@en

CSI position statement on management of heart failure in India

@nl

P1476

CSI position statement on management of heart failure in India

@en

P2093

A K Pancholia

http://www.w3.org/2001/XMLSchema#string

Aditya Kapoor

http://www.w3.org/2001/XMLSchema#string

Ajay Sinha

http://www.w3.org/2001/XMLSchema#string

Ajaykumar U Mahajan

http://www.w3.org/2001/XMLSchema#string

Amal Kumar Banerjee

http://www.w3.org/2001/XMLSchema#string

Ambuj Roy

http://www.w3.org/2001/XMLSchema#string

Amit Vora

http://www.w3.org/2001/XMLSchema#string

Anita Saxena

http://www.w3.org/2001/XMLSchema#string

Arup Dasbiswas

http://www.w3.org/2001/XMLSchema#string

B C Srinivas

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Dose–Response Relationship Between Physical Activity and Risk of Heart FailureCLINICAL PERSPECTIVE

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction

Coenzyme Q10 for heart failure

Exercise-based rehabilitation for heart failure

Anti-inflammatory treatment for carditis in acute rheumatic fever

Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis

Rheumatic fever & rheumatic heart disease: the last 50 years

Pericardial disease: diagnosis and management

P304

S1-S72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IHJ.2018.05.003

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

70 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Kewal K Talwar

Akshyaya Pradhan

Vimal Raj

P577

2018-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30122238

http://www.w3.org/2001/XMLSchema#string

P932

6097178

http://www.w3.org/2001/XMLSchema#string